BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 18302259)

  • 1. Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy.
    Mucha-Małecka A; Małecki K; Amrogowicz N; Biesaga B; Modrzejewski M
    Sci Rep; 2021 Sep; 11(1):17717. PubMed ID: 34489495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Human Papilloma Virus 16/18 In Laryngeal Carcinoma with Correlation to the Expression of Cyclin D1, p53, p16 and EGFR.
    Tariq N; Mirza T; Ansari M; Nazir S
    Pak J Med Sci; 2023; 39(6):1768-1773. PubMed ID: 37936777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of VEGF and cyclin D1/EGFR in common primary liver carcinomas in Egypt: an immunohistochemical study.
    Sweed D; Gammal SSE; Kilany S; Abdelsattar S; Elhamed SMA
    Ecancermedicalscience; 2023; 17():1641. PubMed ID: 38414954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Study the Role of PTEN, EGFR and HER2 in Early Glottic Squamous Cell Carcinoma.
    Goel S; Batra A; Singhal G; Goel S
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):707-712. PubMed ID: 37275058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review.
    Noordhuis MG; Kop EA; van der Vegt B; Langendijk JA; van der Laan BFAM; Schuuring E; de Bock GH
    Clin Otolaryngol; 2020 Jul; 45(4):486-494. PubMed ID: 32246586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN Is Associated With Worse Local Control in Early Stage Supraglottic Laryngeal Cancer Treated With Radiotherapy.
    Bruine de Bruin L; Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik MF; Langendijk JA; van der Wal JE; Schuuring E; van der Laan BFAM
    Laryngoscope Investig Otolaryngol; 2019 Aug; 4(4):399-404. PubMed ID: 31453348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.
    Bossi P; Resteghini C; Paielli N; Licitra L; Pilotti S; Perrone F
    Oncotarget; 2016 Nov; 7(45):74362-74379. PubMed ID: 27556186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.
    Della Vittoria Scarpati G; Perri F; Pisconti S; Costa G; Ricciardiello F; Del Prete S; Napolitano A; Carraturo M; Mazzone S; Addeo R
    Mol Clin Oncol; 2016 Apr; 4(4):467-471. PubMed ID: 27073643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis.
    Hagen KR; Zeng X; Lee MY; Tucker Kahn S; Harrison Pitner MK; Zaky SS; Liu Y; O'Regan RM; Deng X; Saavedra HI
    Cell Div; 2013 Jul; 8(1):10. PubMed ID: 23886499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of a direct role for cyclin d1 in DNA damage repair.
    Jirawatnotai S; Hu Y; Livingston DM; Sicinski P
    Cancer Res; 2012 Sep; 72(17):4289-93. PubMed ID: 22915759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in initial management of laryngeal cancer: the declining use of open surgery.
    Silver CE; Beitler JJ; Shaha AR; Rinaldo A; Ferlito A
    Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1333-52. PubMed ID: 19597837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of EGF receptor expression in early glottic cancer.
    Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
    Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG; Steiniche T; Overgaard J;
    Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
    Morshed K; Skomra D; Korobowicz E; Szymański M; Polz-Dacewicz M; Gołabek W
    Acta Otolaryngol; 2007 Jul; 127(7):760-9. PubMed ID: 17573573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.
    Smith BD; Haffty BG
    Radiat Oncol Investig; 1999; 7(3):125-44. PubMed ID: 10406054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based review of treatment options for patients with glottic cancer.
    Hartl DM; Ferlito A; Brasnu DF; Langendijk JA; Rinaldo A; Silver CE; Wolf GT
    Head Neck; 2011 Nov; 33(11):1638-48. PubMed ID: 21990228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR; Wu HG; Park CI; Jun YK; Kim CW
    Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.